BioWorld - Tuesday, December 30, 2025

BioWorld Science

Aug. 20, 2018

View Archived Issues

TGF-beta inhibition restores regeneration in acute liver injury

Read More

Discovery of a druggable target for traumatic brain injury

Read More

Sumitomo Dainippon Pharma divulges dopamine D1/D2 and/or 5-HT2A receptor antagonists

Read More

Biogen patents nuclear factor erythroid 2-related factor 2 activators

Read More

Novel animal model of glaucoma created using tree shrews

Read More

New lysine-specific histone demethylase 1A inhibitors identified at Medshine Discovery

Read More

Elevated FGF23, a causative factor in the development of renal anemia and iron deficiency

Read More

Lilly discovers N-Acetyl-beta-D-glucosaminidase inhibitors

Read More

FDA approves Opdivo for metastatic SCLC that has progressed after platinum-based chemotherapy

Read More

GlaxoSmithKline describes discovery of DNMT1 inhibitors at fall ACS National Meeting

Read More

FDA places partial clinical hold on Study OX1222 of OXi-4503

Read More

Target of rapamycin complex 1 inhibition improves immune function in elderly subjects

Read More

Immunocore initiates phase I study of IMCnyeso under GSK collaboration

Read More

Tumors in brain lead to T cells in bone

Read More

Vaccinations initiated in first-in-human trial of novel attenuated Zika vaccine

Read More

Let there be no light damage

Read More

FDA approves Eylea injection sBLA in wet AMD

Read More

European clearance for phase II study of SENS-401 for sudden sensorineuronal hearing loss

Read More

Celleron enrolls first patient in phase Ib/II study of CXD-101 with nivolumab for colorectal cancer

Read More